실시간 정량적 중합효소연쇄반응을 이용한 Real-Q HBV Quantification Kit의성능평가
Performance Evaluation of Real-Q HBV Quantification Kit for HBV DNA by Real-Time PCR
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
배경 : Hepatitis B virus (HBV) DNA 정량검사는 항바이러스제제의 사용, 치료효과 추적, 내성 HBV의 조기 진단 등 HBV감염의 치료를 위해 필요하다. 최근 검사실에 보급되고 있는 real-time quantitative PCR은 기존의 HBV DNA 검사법의 단점들을 보완하면서 보다 간편하고 정확한 HBV DNA 정량 기법이다.본 연구에서는 최근 국내에서 개발된 Real-Q HBV Quantifica-tion kit의 성능을 평가하였다.방법 : Real-Q HBV Quantification kit의 회수율, 검출 한계,분석특이도 및 진단특이도, 정밀도, 직선성 범위, 그리고 DigeneHybrid-Capture II와 상관성과 internal control (IC)의 간섭영향을 분석하였다.결과 : 평균 %회수율은 108.6% 이었으며, 동일 검체에서 IC과의 경쟁 때문에 target 유전자의 증폭이 억제되지 않음을 확인하였다. Hepatitis C virus (HCV), human immunodeficiency virus(HIV), Cytomegalovirus (CMV) 19개의 양성 검체와 교차반응은 없었으며, 본 검사의 재현성은 검사차례내 변이계수 8.7-11.9%,검사차례간 변이계수 10.5-14.7%, 검사일간 변이계수 13.2-21.4%를 보였다. 검출 한계는 56 copies/mL이었으며, 보고범위는 102-1× 1010 copies/mL이었다, HBV 음성 100검체를 이용하여 분석한 진단특이도는 100%이었고, Digene Hybrid-Capture II와 우수한 상관관계를 보였다(R2=0.9827).
Abstract
Background : Hepatitis B virus (HBV) DNA quantification is important for the management of HBV infection and identification of the development of resistance. The susceptibility to contamination and more variable reproducibility of results with the conventional HBV DNA quantification method have raised the need of a more simple and accurate method for HBV DNA quantification. Real-time quantitative PCR assays recently introduced in the laboratory can meet these needs. In this study, we evaluated the performance of the Real-Q HBV Quantification kit developed in Korea. Methods : We evaluated the recovery of DNA extraction, the interference of internal control, an analytical sensitivity, specificity, and reproducibility, a clinical specificity, and a reportable range of the Real-Q HBV Quantification kit. The quantification result was also compared to that obtained by the Digene Hybrid-Capture II. Results : The mean percent recovery was 108.6% and there was no interference with the internal control on DNA extraction. None of HIV, hepatitis C virus, or cytomegalovirus showed a cross-reactivity with HBV. This assay detected HBV DNA in a linear range from 102 to 1010 copies/mL, with the detection limit of 56 copies/mL. The assay exhibited a low within-run CV (coefficient of variation) (8.711.9%), between-run CV (10.5-14.7%), and between-day CV (13.2-21.4%). No HBV DNA was detected in any of 100 samples without HBV, resulting in a clinical specificity of 100%. The levels of HBV DNA showed a good correlation with those determined with Digene Hybrid-Capture II (R2=0.9827). Conclusions : The Real-Q HBV Quantification kit showed a good analytical sensitivity, specificity, and high reliability with a broad reportable range. This assay should be clinically useful in managing patients with HBV infection. (Korean J Lab Med 2006;26:442-8)
참고문헌 (27)
- "Clinical evaluation and applications of the Amplicor HBVMonitor test,a quantitative HBV DNA PCR assay", 74, pp.155~165 (1998)
- "Quantitative detection of hepatitis B virus DNA with a newPCR assay", 36, pp.601~604 (1998)
- "Branched DNA amplification multimers for the sensitive,directdetection of human hepatitis viruses", 24, pp.197~200 (1991)
- "Quantitation of HBV DNA in human serum using a bran-ched DNA(bDNA)signal amplification assay", 104, pp.537~546 (1995)
- "What technique should be used for routine detection and quan-tification of HBV DNA in clinical samples", 65, pp.245~253 (1997)
- "Routine detection and quantification of hepatitis B virus DNAin clinical laboratories:performance of three commercial assays", 85, pp.11~21 (2000)
- "Detection of serum hepatitis B virus DNA by real-time quan-titative polymerase chain reaction (TaqMan PCR) during lamivu-dine treatment: comparison with three other assays.", 26, pp.125~133 (2003)
- "A rapidreal-time quantitative polymerase chain reaction for hepatitis B virus", 93, pp.105~113 (2001)
- "Development and assessment of a novelreal-time PCR assay for quantitation of HBV DNA", 103, pp.201~212 (2002)
- "Real-time PCR in the microbiology laboratory", 10, pp.190~212 (2004)
- "Fluorescence resonance energy transfer and nucleic acids", 211, pp.353~88 (1992)
- "Fluorescence resonance energy transfer", 246, pp.300~334 (1995)
- "Detection ofspecific polymerase chain reaction product by utilizing the 5′----3′exonuclease activity of Thermus aquaticus DNA polymerase", 88, pp.7276~80 (1991)
- "Allelic discrimination by nick-trans-lation PCR with fluorogenic probes", 21, pp.3761~6 (1993)
- "The power of real-time PCR", 29, pp.151~159 (2005)
- "Hepatitis B. Fact Sheet No. 204"
- "Annualreport on external quality assessment in diagnostic genetics in Korea(2004).", 27, pp.141~165 (2005)
- "Quantita-tive polymerase chain reaction assay for serum hepatitis B virusDNA as a predictive factor for post-treatment relapse after lamivu-dine induced hepatitis B e antigen loss or seroconversion", 52, pp.1779~1783 (2003)
- "Quantification using real-time PCR technology:applica-tions and limitations", 8, pp.257~260 (2002)
- "Real-time quantitative PCR inparasitology", 18, pp.337~342 (2002)
- "Gene quantification using real-time quantitative PCR:an emerging technology hits the mainstream.", 30, pp.503~512 (2002)
- "Quantitative real-time RT-PCR usinghybridization probes and imported standard curves for cytokinegene expression analysis", 33, pp.1078~1084 (2002)
- "The real-time polymerase chain reaction", 27, pp.95~125 (2006)
- "Rapidquantification of hepatitis B virus DNA by real-time PCR using flu-orescent hybridization probes", 52, pp.397~402 (2003)
- "Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard", 30, pp.86~93 (2004)
- "Quantitative analysis of hepatitis B virus DNA by real-time amplification", 21, pp.22~26 (2002)
- "Fully automated quantitation of hepatitis B virus(HBV)DNA in human plasma by the COBAS AmpliPrep", COBAS Taq-Man system, 2006, pp.35, 373~380
